Initial Statement of Beneficial Ownership (3)
November 12 2019 - 9:55AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Barichivich John Clarence III |
2. Date of Event Requiring Statement (MM/DD/YYYY)
11/7/2019
|
3. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ALB]
|
|
(Last)
(First)
(Middle)
ALBEMARLE CORPORATION, 4250 CONGRESS STREET, SUITE 900 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
VP, Controller & CAO / |
|
(Street)
CHARLOTTE, NC 28209
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4) | 2. Amount of Securities Beneficially Owned
(Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) | 4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Common Stock | 1891 | D | |
| Common Stock | 1187 | I | Albermarle Savings Plan (1) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4) | 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) | 6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Performance Unit | (2) | (2) | Common Stock | 266.0 | $0.0 | D | |
| Restricted Stock Unit | (3) | (3) | Common Stock | 266.0 | $0.0 | D | |
| Restricted Stock Unit | (4) | (4) | Common Stock | 674.0 | $0.0 | D | |
| Restricted Stock Unit | (5) | (5) | Common Stock | 528.0 | $0.0 | D | |
| Restricted Stock Unit | (6) | (6) | Common Stock | 826.0 | $0.0 | D | |
| Explanation of Responses: |
| (1) | Total number of shares of Common Stock held in the name of the Reporting Person under the Albemarle Corporation Retirement Savings Plan as of the date of this Form 3. |
| (2) | Performance Units granted on 2/26/2016. First 50% vested on 2/26/2019 and second 50% vests on 2/26/2020. Each Performance Unit converts to 1 share of Common Stock. |
| (3) | On 2/26/2016, the reporting person was granted 532 Restricted Stock Units, vesting on each of the third and fourth anniversary of the grant date in 2019 and 2020. First 50% vested on 2/26/2019 and second 50% vests on 2/26/2020. Each Restricted Stock Unit converts to 1 share of Common Stock. |
| (4) | On 2/24/2017, the reporting person was granted 674 Restricted Stock Units, vesting on each of the third and fourth anniversary of the grant date in 2020 and 2021. First 50% will vest on 2/24/2020 and second 50% will vest on 2/24/2021. Each Restricted Stock Unit converts to 1 share of Common Stock. |
| (5) | On 2/23/2018, the reporting person was granted 528 Restricted Stock Units, vesting on each of the third and fourth anniversary of the grant date in 2021 and 2022. First 50% will vest on 2/23/2021 and second 50% will vest on 2/23/2022. Each Restricted Stock Unit converts to 1 share of Common Stock. |
| (6) | On 2/26/2019, the reporting person was granted 826 Restricted Stock Units, vesting on each of the third and fourth anniversary of the grant date in 2022 and 2023. First 50% will vest on 2/26/2022 and second 50% will vest on 2/26/2023. Each Restricted Stock Unit converts to 1 share of Common Stock. |
Remarks:
Exhibit List
Exhibit 24 - Power of Attorney |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Barichivich John Clarence III
ALBEMARLE CORPORATION
4250 CONGRESS STREET, SUITE 900
CHARLOTTE, NC 28209 |
|
| VP, Controller & CAO |
|
Signatures
|
| /s/ Brenda Mareski, attorney-in-fact | | 11/12/2019 |
| **Signature of Reporting Person | Date |
Albemarle (NYSE:ALB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Albemarle (NYSE:ALB)
Historical Stock Chart
From Sep 2023 to Sep 2024
